BY MARKETWIRE
-
Novo Nordisk expected to upgrade guidance after double-digit growth in the first half
Experts anticipate Novo Nordisk to upgrade its top-line projection to 22-28 percent development.
-
Sonova launches two new platforms and AI-powered premium product
Phonak Audéo Round Infinio will certainly be the initial listening device on the marketplace to be straight sustained by expert system, supplying real-time assistance in various sc…
-
Bavarian Nordic receives USD 150m order for pox vaccine from US authorities
The agreement has no influence on Bavarian Nordic’s economic advice for 2024.
-
Novo Nordisk makes extra doses of obesity drug available in US
Novo Nordisk has actually highlighted a number of times in the past that need is most likely to remain to overtake supply for time.
-
Amgen increases obesity investment
Amgen remains to try to find its following large item as sales development is largely driven by older medicines.
-
Novo Nordisk withdraws application for Wegovy within cardiovascular disease
The pharmaceutical company will reapply in 2025.
-
Novo Nordisk analyst on strong sales figures from Eli Lilly: In the short term, it helps
According to an expert, both rivals are presently concentrating on constructing the marketplace around excessive weight medicine specifically.
-
GN expands top product range
The Danish listening devices producer released its tiniest in-the-canal listening devices on Thursday.
-
Novo Nordisk to present more obesity data in the year’s second half
To name a few statements, prepared for stage III outcomes will certainly be revealed for the follower to Wegovy, cagrisema, prior to completion of the year.
-
Where to Watch Emily in Paris
If you’re wondering where to watch Emily in Paris online for the lowest cost, you’re in the right place. Emily in Paris, the charming and glamorous TV series, has captivated……
